Dr. James C. Cripe, MD

Dr. Cripe practices at Community Health Network in Indianapolis, Indiana.

Dr. Cripe's NPI, 1679860894, was assigned on July 8, 2011. Dr. Cripe holds Indiana license 01081421A.

Dr. Cripe's primary practice is Community Health Network, at 7240 Shadeland Sta, Indianapolis, IN 46256 in Marion County. The practice phone is (317) 355-5555.

Dr. Cripe's primary practice is Community Health Network in Indianapolis, Indiana. Dr. Cripe is also affiliated with Community Hospital East. The medical group on file is Community Physician Network. Dmand AI also links Dr. Cripe to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cripe practices, 6 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Cripe's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. Cripe's licenses on file in 2 states: Indiana and Missouri.

CMS data shows 209 Medicare services from Dr. Cripe across 6 procedure codes in 2024, for 138 Medicare patients. Medicare paid $27,795 for them.

CMS counts 138 Medicare patients who saw Dr. Cripe in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cripe's median patient age at 63, with 99% women.

In 2024, Dr. Cripe wrote 60 Medicare Part D claims for 34 patients. 82% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $51 in total drug cost. In 2022, CMS named 23 claims across 2 drugs.

Dr. Cripe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 32 procedures of removal of the uterus by Dr. Cripe, more than 97% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Cripe, published from 2014 to 2022. 2019 was the busiest year, with 5. The most frequent topics are Endometrial Neoplasms, Genital Neoplasms, Female and Antineoplastic Combined Chemotherapy Protocols. Dr. Cripe has published most often in Gynecol Oncol. Dr. Cripe's most frequent co-authors are Premal Harish Thaker, MD, David Mutch, DO and Katherine Cynthia Fuh, MD.

Dmand AI links Dr. Cripe to 2 clinical trials. Conditions studied include Pre-Eclampsia and Hypertension, Pregnancy-Induced.

CMS Open Payments shows 60 general payments to Dr. Cripe from 21 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $410.